Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
News & Events
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Summary of Direct Healthcare Professional Communications (DHPCs) issued in January 2019
News Category:
3rd party
Date:
04/02/2019
Please find below the links to all Direct Healthcare Professional Communications (DHPCs) issued in January 2019
18.01.2019
Medicinal products containing carbimazole or thiamazole - Important Safety Info from Amdipharm Limited and Essential-Healthcare Ltd as approved by the HPRA
22.01.2019
Sodium-Glucose-Co-Transporter 2 inhibitors (SGLT2i) - Important Safety Information from marketing authorisation holders of products containing SGLT2 inhibitors as approved by the HPRA
31.01.2019
Lartruvo (olaratumab) - Important Safety Information from Eli Lilly & Company as approved by the HPRA
« Back
Date Printed: 11/11/2024